These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28064403)

  • 1. Knockdown of clusterin alters mitochondrial dynamics, facilitates necrosis in camptothecin-induced cancer stem cells.
    Arumugam P; Samson A; Ki J; Song JM
    Cell Biol Toxicol; 2017 Jun; 33(3):307-321. PubMed ID: 28064403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal co-delivery-based quantitative evaluation of chemosensitivity enhancement in breast cancer stem cells by knockdown of GRP78/CLU.
    Samson AAS; Park S; Kim SY; Min DH; Jeon NL; Song JM
    J Liposome Res; 2019 Mar; 29(1):44-52. PubMed ID: 29262741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative evaluation of ABC transporter-mediated drug resistance based on the determination of the anticancer activity of camptothecin against breast cancer stem cells using TIRF.
    Arumugam P; Song JM
    Integr Biol (Camb); 2016 Jun; 8(6):704-11. PubMed ID: 27182942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of resistance to chemotherapeutic drugs in human osteosarcoma cell lines largely depends on up-regulation of Clusterin/Apolipoprotein J.
    Lourda M; Trougakos IP; Gonos ES
    Int J Cancer; 2007 Feb; 120(3):611-22. PubMed ID: 17096323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of clusterin, XIAP and survivin, and their changes by camptothecin (CPT) treatment in CPT-resistant PC-3 and CPT-sensitive LNCaP cells.
    Mizutani K; Matsumoto K; Hasegawa N; Deguchi T; Nozawa Y
    Exp Oncol; 2006 Sep; 28(3):209-15. PubMed ID: 17080014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
    Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GRP78 regulates clusterin stability, retrotranslocation and mitochondrial localization under ER stress in prostate cancer.
    Li N; Zoubeidi A; Beraldi E; Gleave ME
    Oncogene; 2013 Apr; 32(15):1933-42. PubMed ID: 22689054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
    Ray S; Almasan A
    Cancer Res; 2003 Aug; 63(15):4713-23. PubMed ID: 12907654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of adenine nucleotide translocase 3 and its role in camptothecin-induced apoptosis in human hepatoma QGY7703 cells.
    Hu Z; Guo X; Yu Q; Qiu L; Li J; Ying K; Guo C; Zhang J
    FEBS Lett; 2009 Jan; 583(2):383-8. PubMed ID: 19111545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRLX101, an investigational camptothecin-containing nanoparticle-drug conjugate, targets cancer stem cells and impedes resistance to antiangiogenic therapy in mouse models of breast cancer.
    Conley SJ; Baker TL; Burnett JP; Theisen RL; Lazarus D; Peters CG; Clouthier SG; Eliasof S; Wicha MS
    Breast Cancer Res Treat; 2015 Apr; 150(3):559-67. PubMed ID: 25833208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clusterin facilitates stress-induced lipidation of LC3 and autophagosome biogenesis to enhance cancer cell survival.
    Zhang F; Kumano M; Beraldi E; Fazli L; Du C; Moore S; Sorensen P; Zoubeidi A; Gleave ME
    Nat Commun; 2014 Dec; 5():5775. PubMed ID: 25503391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CLU (clusterin) promotes mitophagic degradation of MSX2 through an AKT-DNM1L/Drp1 axis to maintain SOX2-mediated stemness in oral cancer stem cells.
    Praharaj PP; Patra S; Mishra SR; Mukhopadhyay S; Klionsky DJ; Patil S; Bhutia SK
    Autophagy; 2023 Aug; 19(8):2196-2216. PubMed ID: 36779631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Down-regulated clusterin expression enhances sensitivity of hepatoma cells to anti-cancer drugs].
    Zheng WJ; Sai WL; Yao M; Cai Y; Pan LH; Gu JJ; Wu W; Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2015 Nov; 23(11):844-8. PubMed ID: 26743245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistance.
    Tsou SH; Chen TM; Hsiao HT; Chen YH
    PLoS One; 2015; 10(1):e0116747. PubMed ID: 25635866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-195 regulates docetaxel resistance by targeting clusterin in prostate cancer.
    Ma X; Zou L; Li X; Chen Z; Lin Q; Wu X
    Biomed Pharmacother; 2018 Mar; 99():445-450. PubMed ID: 29665645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clusterin protects hepatocellular carcinoma cells from endoplasmic reticulum stress induced apoptosis through GRP78.
    Wang C; Jiang K; Gao D; Kang X; Sun C; Zhang Q; Li Y; Sun L; Zhang S; Guo K; Liu Y
    PLoS One; 2013; 8(2):e55981. PubMed ID: 23457489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clusterin alleviates Cr(VI)-induced mitochondrial apoptosis in L02 hepatocytes via inhibition of Ca
    Tang S; Ye S; Ma Y; Liang Y; Liang N; Xiao F
    Ecotoxicol Environ Saf; 2020 Dec; 205():111326. PubMed ID: 32961495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clusterin is a critical downstream mediator of stress-induced YB-1 transactivation in prostate cancer.
    Shiota M; Zoubeidi A; Kumano M; Beraldi E; Naito S; Nelson CC; Sorensen PH; Gleave ME
    Mol Cancer Res; 2011 Dec; 9(12):1755-66. PubMed ID: 21987172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
    Goldwasser F; Bae I; Fornace AJ; Pommier Y
    Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional targeting of human liver carboxylesterase (hCE1m6) and simultaneous expression of anti-BCRP shRNA enhances sensitivity of breast cancer cells to CPT-11.
    Mishra MN; Vangara KK; Palakurthi S
    Anticancer Res; 2014 Nov; 34(11):6345-51. PubMed ID: 25368234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.